NIH director announces 2007 Pioneer Award competition

October 12, 2006

NIH Director Elias A. Zerhouni, M.D., today launched a new round of competition for the NIH Director's Pioneer Award. This signature program supports exceptionally creative scientists who take highly innovative--and potentially transformative--approaches to major challenges in biomedical research.

"We hope this opportunity stimulates even more investigators to send us their boldest, most imaginative concepts," said Zerhouni. "The Pioneer Award supports individual scientists rather than specific projects and allows recipients to pursue promising new research directions that could have unusually great impact. This program is one way we are exploring of funding scientists whose ideas might be too novel, span too diverse a range of disciplines, or be at too early a stage to fare well in the traditional NIH peer review process."

Each Pioneer Award provides $2.5 million in direct costs over five years. NIH funded 35 scientists in the first three years of the program, which is part of the NIH Roadmap for Medical Research. In September 2007, the agency expects to make between five and ten new Pioneer Award grants.

Scientists at all career levels and engaged in any field of research may apply for the Pioneer Award, as long as they are interested in exploring biomedically relevant topics.

"We hope to see a diverse applicant pool again this year. Toward that end, we continue to encourage applications from women, members of groups that are underrepresented in biomedical research, and individuals in the early to middle stages of their careers," said Jeremy M. Berg, Ph.D., director of the National Institute of General Medical Sciences and a leader of the Pioneer Award program.

The centerpiece of the streamlined, electronic application process is an essay on the investigator's vision for addressing a biomedical challenge, the importance of the problem, and the person's qualifications to engage in groundbreaking research. The application period opens on Friday, December 1, 2006 and closes on Tuesday, January 16, 2007.
Application instructions are at

More information on the Pioneer Award is at

The NIH Roadmap for Medical Research is a series of far-reaching initiatives designed to transform the nation's medical research capabilities and speed the movement of research discoveries from the bench to the bedside. It provides a framework of the priorities the NIH must address in order to optimize its entire research portfolio and lays out a vision for a more efficient and productive system of medical research. For more information about the NIH Roadmap, please visit the Web site at

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH/National Institute of General Medical Sciences

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to